|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
CN1280574A
(en)
|
1997-10-27 |
2001-01-17 |
雷迪研究基金会 |
New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them
|
|
RU2247722C2
(en)
|
1997-10-27 |
2005-03-10 |
Др. Редди`З Лабораториз Лимитед |
Derivatives of aryl carboxylic acids, methods for their preparing, pharmaceutical composition based on thereof, methods for treatment and prophylaxis of different diseases, intermediate compounds and methods for their preparing
|
|
WO1999019313A1
(en)
*
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
BR9812772A
(en)
*
|
1997-10-27 |
2000-10-10 |
Reddy Research Foundation |
"unpublished tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them"
|
|
US6531596B1
(en)
|
1998-10-29 |
2003-03-11 |
Dr. Reddy's Laboratories Ltd. |
Process for the preparation of new antidiabetic agents
|
|
WO2000026200A1
(en)
|
1998-10-29 |
2000-05-11 |
Dr. Reddy's Research Foundation |
An improved process for the preparation of new antidiabetic agents
|
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
|
AU7073400A
(en)
|
1999-08-27 |
2001-03-26 |
Eli Lilly And Company |
Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
|
|
EE05082B1
(en)
*
|
2000-01-19 |
2008-10-15 |
Cadila Healthcare Ltd. |
A Pyrrole Line Compound, its Preparation and Use in the Formulation of a Lipid and Cholesterol Lowering Drug, and a Pharmaceutical Composition Containing it
|
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US6509374B2
(en)
|
2000-04-17 |
2003-01-21 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US6559335B2
(en)
|
2000-09-22 |
2003-05-06 |
Dr. Reddy's Laboratories Limited |
Process for the preparation of 3-aryl-2-hydroxy propanoic acid
|
|
AU2002342244B2
(en)
|
2001-05-15 |
2005-06-16 |
F. Hoffmann-La Roche Ag |
Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes
|
|
SE0101978D0
(en)
*
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
New compounds
|
|
WO2003006022A1
(en)
*
|
2001-07-09 |
2003-01-23 |
Dr. Reddy's Laboratories Ltd. |
Tetrahydroquinoline derivatives and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6987123B2
(en)
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US7015345B2
(en)
|
2002-02-21 |
2006-03-21 |
Asahi Kasei Pharma Corporation |
Propionic acid derivatives
|
|
CA2490152C
(en)
|
2002-07-03 |
2009-04-07 |
F. Hoffmann-La Roche Ag |
Oxazole derivatives and their use as insulin sensitizers
|
|
PL375779A1
(en)
|
2002-08-30 |
2005-12-12 |
F.Hoffmann-La Roche Ag |
Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
|
|
CN100577660C
(en)
|
2002-09-12 |
2010-01-06 |
霍夫曼-拉罗奇有限公司 |
N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists used for the treatment of diabetes
|
|
PL377320A1
(en)
|
2002-11-25 |
2006-01-23 |
F. Hoffmann-La Roche Ag |
Indolyl derivatives
|
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
|
UA110813C2
(en)
|
2011-01-31 |
2016-02-25 |
Каділа Хелткере Лімітед |
Treatment of lipodystrophy
|
|
EP2988736A1
(en)
|
2013-04-22 |
2016-03-02 |
Cadila Healthcare Limited |
A novel composition for nonalcoholic fatty liver disease (nafld)
|
|
EP3004053B1
(en)
|
2013-05-30 |
2021-03-24 |
Cadila Healthcare Limited |
A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
|
|
TW201636015A
(en)
|
2013-07-05 |
2016-10-16 |
卡地拉保健有限公司 |
Synergistic compositions
|
|
IN2013MU02470A
(en)
|
2013-07-25 |
2015-06-26 |
Cadila Healthcare Ltd |
|
|
WO2015033357A2
(en)
|
2013-09-06 |
2015-03-12 |
Cadila Healthcare Limited |
An improved process for the preparation of pyrrole derivatives
|
|
US10385017B2
(en)
|
2015-10-14 |
2019-08-20 |
Cadila Healthcare Limited |
Pyrrole compound, compositions and process for preparation thereof
|
|
US20180243263A1
(en)
|
2016-12-09 |
2018-08-30 |
Cadila Healthcare Ltd. |
Treatment for primary biliary cholangitis
|